ID: ALA519009

Max Phase: Preclinical

Molecular Formula: C12H10ClN5O

Molecular Weight: 275.70

Molecule Type: Small molecule

Representations

Canonical SMILES:  COc1ccc(Nc2nc(Cl)nc3[nH]cnc23)cc1

Standard InChI:  InChI=1S/C12H10ClN5O/c1-19-8-4-2-7(3-5-8)16-11-9-10(15-6-14-9)17-12(13)18-11/h2-6H,1H3,(H2,14,15,16,17,18)

Standard InChI Key:  IKEILORHEXEGSD-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 275.70

Molecular Weight (Monoisotopic): 275.0574

AlogP: 2.76

#Rotatable Bonds: 3

Polar Surface Area: 75.72

Molecular Species: NEUTRAL

HBA: 5

HBD: 2

#RO5 Violations: 0

HBA (Lipinski): 6

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 9.56

CX Basic pKa: 1.30

CX LogP: 2.49

CX LogD: 2.49

Aromatic Rings: 3

Heavy Atoms: 19

QED Weighted: 0.72

Np Likeness Score: -1.04

References

1. Zatloukal M, Gemrotová M, Dolezal K, Havlícek L, Spíchal L, Strnad M..  (2008)  Novel potent inhibitors of A. thaliana cytokinin oxidase/dehydrogenase.,  16  (20): [PMID:18818088] [10.1016/j.bmc.2008.09.008]

Source

Source(1):

• Scientific Literature